These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

52 related articles for article (PubMed ID: 1906197)

  • 1. Pharmacologic profile of sulfamino-galactosaminoglycans.
    Pescador R; Porta R; Mantovani M; Prino G; Casu B; Naggi A; Torri G; Walenga JM; Hoppensteadt DA; Fareed J
    Semin Thromb Hemost; 1991; 17 Suppl 1():74-9. PubMed ID: 1906197
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of polysaccharides enriched in 2,4-disulfated fucose units on coagulation, thrombosis and bleeding. Practical and conceptual implications.
    Fonseca RJ; Santos GR; Mourão PA
    Thromb Haemost; 2009 Nov; 102(5):829-36. PubMed ID: 19888516
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular and functional heterogeneity in dermatan sulfate preparations.
    Fareed J; Hoppensteadt D; Walenga JM; Ahsan A; Coyne E; Breddin HK
    Semin Thromb Hemost; 1991; 17 Suppl 2():174-80. PubMed ID: 1948088
    [No Abstract]   [Full Text] [Related]  

  • 4. Fucosylated chondroitin sulfate as a new oral antithrombotic agent.
    Fonseca RJ; Mourão PA
    Thromb Haemost; 2006 Dec; 96(6):822-9. PubMed ID: 17139379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A survey of the clinical experience with dermatan sulfate.
    Gianese F; Lucchelli PE
    Semin Thromb Hemost; 1991; 17 Suppl 2():199-204. PubMed ID: 1948090
    [No Abstract]   [Full Text] [Related]  

  • 6. [New antithrombotic drugs (excluding plasminogen activators].
    Lecompte T
    Arch Mal Coeur Vaiss; 2001 Nov; 94(11 Suppl):1225-32. PubMed ID: 11794963
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A small fraction of dermatan sulfate with significantly increased anticoagulant activity was selected by interaction with the first complement protein.
    Calabrese GC; Alberto MF; Tubio R; Marani MM; Fernández De Recondo ME; Lazzari M; Recondo EF
    Thromb Res; 2004; 113(3-4):243-50. PubMed ID: 15140589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antithrombotic and anticomplementary properties of a very low molecular mass dermatan sulfate.
    Fabiana Alberto M; Giaquinta Romero D; Lazzari M; Calabrese GC
    Thromb Res; 2008; 122(1):109-16. PubMed ID: 17936880
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Antithrombotic activity of complexes of superoxide dismutase with chondroitin sulfate in arterial damage in rats].
    Maksimenko AV; Tishchenko EG; Golubykh VL
    Vopr Med Khim; 1998; 44(4):353-61. PubMed ID: 9845922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unbalanced effects of dermatan sulfates with different sulfation patterns on coagulation, thrombosis and bleeding.
    Vicente CP; Zancan P; Peixoto LL; Alves-Sá R; Araújo FS; Mourão PA; Pavão MS
    Thromb Haemost; 2001 Nov; 86(5):1215-20. PubMed ID: 11816710
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Antithrombotic effect of catalase and chondroitin sulfate derivatives in arterial damage in rats].
    Maksimenko AV; Tishchenko EG; Golybykh VL
    Vopr Med Khim; 1998; 44(4):362-8. PubMed ID: 9845923
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pharmacologic profile of the antithrombotic and bleeding actions of sulfated lactobionic acid amides.
    Raake W; Klauser RJ; Meinetsberger E; Zeller P; Elling H
    Semin Thromb Hemost; 1991; 17 Suppl 1():129-35. PubMed ID: 2068566
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anticoagulant and antithrombotic evaluation of native fucosylated chondroitin sulfates and their derivatives as selective inhibitors of intrinsic factor Xase.
    Wu M; Wen D; Gao N; Xiao C; Yang L; Xu L; Lian W; Peng W; Jiang J; Zhao J
    Eur J Med Chem; 2015 Mar; 92():257-69. PubMed ID: 25559206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Danaparoid: an anti-thrombotic agent without major impact on triglyceride hydrolysis capacity in humans.
    Mikhailidis DP; Jagroop IA
    J Intern Med; 1998 Aug; 244(2):184. PubMed ID: 10095808
    [No Abstract]   [Full Text] [Related]  

  • 15. Pharmacokinetics of native and low molecular weight dermatans: preliminary studies in rats and primates.
    Bergonzini GL; Bianchini P; Hoppensteadt D; Parma B; Osima B; Walenga JM; Fareed J
    Semin Thromb Hemost; 1991; 17 Suppl 2():235-9. PubMed ID: 1948095
    [No Abstract]   [Full Text] [Related]  

  • 16. Dermatan sulfate as a potential antithrombotic drug.
    Pangrazzi J; Gianese F
    Haematologica; 1987; 72(5):459-64. PubMed ID: 3121470
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacological properties of dermatan sulfate, of a low molecular weight dermatan sulfate and of two oversulfated derivatives.
    Dol F; Petitou M; Choay J; Sie P; Houin G; Boneu B
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(6):851-7. PubMed ID: 2483702
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of glycosaminoglycans on U-937 leukemia cell proliferation and differentiation: structure-function relationship.
    Volpi N; Petrini M; Conte A; Valentini P; Venturelli T; Bolognani L; Ronca G
    Exp Cell Res; 1994 Nov; 215(1):119-30. PubMed ID: 7957660
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antithrombotic activities of fucosylated chondroitin sulfates and their depolymerized fragments from two sea cucumbers.
    Liu X; Hao J; Shan X; Zhang X; Zhao X; Li Q; Wang X; Cai C; Li G; Yu G
    Carbohydr Polym; 2016 Nov; 152():343-350. PubMed ID: 27516281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of cAMP-dependent protein kinase by derivatives of chondroitin sulfate.
    Dittmann J; Krischek C; Harisch G
    Life Sci; 1997; 60(12):PL 201-6. PubMed ID: 9061053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.